Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Teva
AstraZeneca
Cipla
QuintilesIMS
Healthtrust

Generated: March 22, 2019

DrugPatentWatch Database Preview

ESTROGENS, CONJUGATED; MEPROBAMATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for estrogens, conjugated; meprobamate and what is the scope of estrogens, conjugated; meprobamate patent protection?

Estrogens, conjugated; meprobamate is the generic ingredient in four branded drugs marketed by Medpointe Pharm Hlc and Wyeth Ayerst, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estrogens, conjugated; meprobamate.

Summary for ESTROGENS, CONJUGATED; MEPROBAMATE
US Patents:0
Tradenames:4
Applicants:2
NDAs:2
Drug Master File Entries: 3
DailyMed Link:ESTROGENS, CONJUGATED; MEPROBAMATE at DailyMed

US Patents and Regulatory Information for ESTROGENS, CONJUGATED; MEPROBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc MILPREM-200 estrogens, conjugated; meprobamate TABLET;ORAL 011045-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst PMB 400 estrogens, conjugated; meprobamate TABLET;ORAL 010971-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Medpointe Pharm Hlc MILPREM-400 estrogens, conjugated; meprobamate TABLET;ORAL 011045-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for ESTROGENS, CONJUGATED; MEPROBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst PMB 200 estrogens, conjugated; meprobamate TABLET;ORAL 010971-005 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst PMB 400 estrogens, conjugated; meprobamate TABLET;ORAL 010971-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Cantor Fitzgerald
Boehringer Ingelheim
Cipla
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.